Oramed Pharmaceuticals Inc. · NASDAQ:ORMP
Aquamarine Financial (Cayman) Ltd reported a 5.06% stake in Oramed Pharmaceuticals Inc. (Schedule 13G)
Event Jan 14, 2026 · Filed May 15, 2026
Aquamarine Financial (Cayman) Ltd reported a 5.06% stake in Oramed Pharmaceuticals Inc., 2,047,652 shares, as a passive investor on Jan 14, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 5.06%
- Shares
- 2,047,652
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Aquamarine Financial (Cayman) Ltd | 5.06% | 2,047,652 |
Source
Related
- Oramed Pharmaceuticals Inc.
- Aquamarine Financial (Cayman) Ltd
- Oramed Pharmaceuticals Inc. shareholders
- Schedule 13G/A · Aquamarine Financial (Cayman) Ltd · Aug 14, 2026
- Form 4 · Gabay Avraham · Oct 2, 2026
- Form 4 · Hexter Joshua · Oct 2, 2026
- Form 4 · Kidron Nadav · Sep 25, 2026
- Form 4 · Hexter Joshua · Sep 25, 2026
- Form 4 · Kidron Miriam · Sep 25, 2026